🟢 Connect Biopharma is trading 7.4% up today in pre-market as biotech ETF XBI gains 2.61%

Connect Biopharma is trading at $1.15, up 7.41%, in a move that appears primarily sector-driven as biotechnology ETF XBI rises 2.61% pre-market.

• The rebound reverses part of the 11.93% decline on September 23 and follows recent weakness after mixed rademikibart Phase 2 results.
• No new company-specific announcement was identified for September 24; the latest listed release remains the September 15 asthma-study update.
• The move comes despite broader indexes trading lower.